Litcius/Paper detail

Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial

Peter Grimison, Antony Mersiades, Adrienne Kirby, Nicholas Lintzeris, Rachael L. Morton, Paul Haber, Ian Olver, Alexandra Walsh, Iain S. McGregor, Y. Cheung, Annette Tognela, Carmel Hahn, Karen Briscoe, Morteza Aghmesheh, Peter Fox, Ehtesham Abdi, Stephen Clarke, Stephen Della‐Fiorentina, Jenny Shannon, Craig Gedye, Stephen Begbie, John Simes, Martin R. Stockler

2020Annals of Oncology153 citationsDOIOpen Access PDF

Topics & Concepts

MedicineNauseaVomitingPlaceboChemotherapy-induced nausea and vomitingCrossover studyRefractory (planetary science)CannabisChemotherapyAnesthesiaAntiemeticCannabidiolRandomized controlled trialPharmacologyInternal medicinePsychiatryPathologyAlternative medicineAstrobiologyPhysicsNausea and vomiting managementCannabis and Cannabinoid ResearchPain Management and Placebo Effect
Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial | Litcius